Overview

Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome

Status:
Terminated
Trial end date:
2010-02-26
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine the effect of testosterone treatment on insulin in men with the metabolic syndrome with testosterone levels at or below the lower end of the normal range.
Phase:
Phase 1
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
American Diabetes Association
National Institutes of Health (NIH)
Treatments:
Anastrozole
Goserelin
Insulin
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate